Centre Cracks Down On 16 Drug Combinations Amid Growing Safety Concerns Nationwide

The Central government has banned the manufacture, sale, distribution and supply of 16 fixed-dose combination (FDC) drugs across India, citing concerns over public health and concluding that the medicines lack adequate therapeutic justification. The prohibition comes into effect immediately and follows a detailed review of such drug combinations by regulatory and expert bodies.

Announcing the decision, the Union Health Ministry said the continued use of the identified FDCs was not considered beneficial when weighed against the potential risks associated with them. The move is aimed at safeguarding public health, promoting the rational use of medicines and ensuring that only scientifically validated and effective treatments remain available in the market.

Fixed-dose combination drugs contain two or more active pharmaceutical ingredients (APIs) combined in a fixed ratio within a single formulation. While such combinations can offer advantages such as improved patient compliance and simplified treatment regimens, health authorities have repeatedly raised concerns about products that lack sufficient scientific evidence or clinical justification.

Also Read: Trump’s “Israel Does As I Say” Claim Followed by Fresh Lebanon Strikes Killing Five

The latest action follows a review process initiated in compliance with directions issued by the Supreme Court. As part of the exercise, the Drugs Technical Advisory Board (DTAB), the country's highest statutory body on technical matters related to drugs, constituted an expert committee to evaluate various FDC formulations available in the market. The panel was tasked with identifying combinations that were irrational, therapeutically unjustified or potentially harmful to patients.

Based on the committee's findings, the government concluded that the 16 identified FDCs did not meet the required standards of safety and efficacy. "The manufacture for sale, sale, distribution and supply of the identified 16 FDCs for human use shall stand prohibited with immediate effect across the country," the Health Ministry said in its notification. The authorities believe the measure will help reduce the risk of inappropriate medication use and improve patient safety.

The decision is part of a broader effort by regulators to strengthen oversight of pharmaceutical products and ensure evidence-based healthcare practices. In recent years, the government has reviewed and prohibited several drug combinations found to be lacking adequate scientific support. Health experts have often argued that irrational FDCs can contribute to adverse drug reactions, ineffective treatment outcomes and increased healthcare risks, making regulatory scrutiny essential for protecting public health.

Also Read: Kerala High Court Directs Police Protection for Kumbh Mela Girl Facing Kidnapping Case